IP Library Granted Patent US 8,293,813
Granted Patent B2
US 8,293,813 · App. 12/397,959 · Granted Oct 23, 2012

Cohesive and compression resistant demineralized bone carrier matrix

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,813
App. No.
12/397,959
Granted
Oct 23, 2012
Kind
B2
Abstract

The present invention provides a demineralized bone carrier matrix which is tolerant of bending, stretching and compression. The material comprises a carrier base material cross-linked with a multifunctional polymer. Demineralized bone matrix may be dispersed with the carrier matrix. The demineralized bone carrier matrix may be used as a bone graph substitute. Methods for making the carrier matrix are also provided.

Claims (12)

1. A compression resistant osteoinductive demineralized bone carrier matrix comprising:

a crosslinked matrix, the crosslinked matrix comprising a carrier base material crosslinked with a multifunctional poly(ethylene glycol), wherein the carrier base material is a gelatin and wherein the multifunctional poly(ethylene glycol) has a functionality of about 2 to about 4;

a demineralized bone matrix, wherein the demineralized bone matrix is dispersed throughout the crosslinked matrix, and wherein the osteoinductive demineralized bone carrier matrix comprises from at least 10 wt% to about 30 wt% of the carrier base material, from about 0.1% to about 4 wt% of the multifunctional poly(ethylene glycol) and from greater than about 55 wt% to about 75 wt% of the demineralized bone matrix with respect to a dry weight of the osteoinductive demineralized bone carrier matrix, and

a ceramic material consisting of hydroxyapatite and calcium carbonate,

wherein the demineralized bone carrier matrix, once introduced to an intramuscular implantation site, induces bone formation such that at least 1% of the implantation site is involved in new bone or cartilage.

2. The osteoinductive demineralized bone carrier matrix of claim 1 wherein the multifunctional poly(ethylene glycol) has at least two functional groups.

3. The osteoinductive demineralized bone carrier matrix of claim 1 wherein the multifunctional poly(ethylene glycol) is homofunctional.

4. The osteoinductive demineralized bone carrier matrix of claim 1 wherein the multifunctional poly(ethylene glycol) is heterfunctional.

5. The osteoinductive demineralized bone carrier matrix of claim 1 wherein at least one functional group of the multifunctional poly(ethylene glycol) reacts with an amino group of the gelatin.

6. The osteoinductive demineralized bone carrier matrix of claim 1 wherein at least one of the functional groups of the multifunctional poly(ethylene glycol) is a succinimidyl glutarate ester.

7. The osteoinductive demineralized bone carrier matrix of claim 1 wherein the crosslinked matrix does not dissolve after being exposed for one hour in water having a temperature of 47° C.

8. The osteoinductive demineralized bone carrier matrix of claim 1 wherein the multifunctional poly(ethylene glycol) has a molecular weight of at least 3,000 and no more than 10,000.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241 Recorded Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC.; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTR-OBIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
Reel/Frame 037155/0082 →
CHANGE OF NAME Recorded Jul 19, 2013
From: BIOMET MANUFACTURING CORPORATION
To: BIOMET MANUFACTURING, LLC
Reel/Frame 030837/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2010
From: BIOMET, INC.
To: BIOMET MANUFACTURING CORPORATION
Reel/Frame 024752/0433 →
SECURITY AGREEMENT Recorded Nov 12, 2009
From: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTRO-BIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 023505/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2009
From: TROXEL, KAREN; GIBBS, BARBARA S.
To: BIOMET, INC.
Reel/Frame 022682/0085 →